Showing 15,121 - 15,140 results of 42,914 for search '(( 5 ((mean decrease) OR (point decrease)) ) OR ( 100 ((teer decrease) OR (a decrease)) ))', query time: 1.03s Refine Results
  1. 15121
  2. 15122
  3. 15123
  4. 15124

    Modulation of Aβ-induced deleterious signaling. by Tao Yang (184280)

    Published 2008
    “…(H) In DIV 21–22 hippocampal neuronal cultures examined at the 3 hour time point, Aβ significantly decreased CREB phosphorylation by 43%, while this decrease was prevented by LM11A-24 and -31 (n = 10 separate Western blots from 5 independent protein preparations).…”
  5. 15125
  6. 15126

    Baseline characteristics of the study sample<sup>β</sup>μ. by Osama Mohamed Ibrahim (12006954)

    Published 2024
    “…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”
  7. 15127

    The flow diagram of the study (CONSORT, 2010). by Osama Mohamed Ibrahim (12006954)

    Published 2024
    “…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”
  8. 15128

    Table_1_Incidence and risk factors of severe acute high-altitude illness in healthy adults first entering the northern Tibetan Plateau of over 5,000 m.DOC by Chun Gao (622218)

    Published 2024
    “…</p>Conclusion<p>Living at lower altitudes and having a decreased lymphocyte level were the risk factors of severe AHAI in healthy adults first entering the plateau of over 5,000 m.…”
  9. 15129

    <i>Cobl</i> KO mice fail to show repair of the dendritic arborization defects caused by MCAO in both layer II/III and layer V neurons of the ipsilateral hemisphere. by Yuanyuan Ji (455424)

    Published 2021
    “…Note that dendritic branching points (<b>E</b>), dendritic terminal points (<b>F</b>), total dendritic tree length (<b>G</b>), and Sholl intersections (<b>H-J</b>) were all decreased at 24 hours after MCAO and that, in contrast to WT animals (<b><a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001399#pbio.3001399.g005" target="_blank">Fig 5</a></b>), none of these phenotypical parameters recovered during the days after MCAO in <i>Cobl</i> KO mice. …”
  10. 15130
  11. 15131
  12. 15132
  13. 15133
  14. 15134
  15. 15135
  16. 15136

    Silencing KDM2A enhances angiogenic tubulogenesis. by Wasia Rizwani (369727)

    Published 2014
    “…<p>(A) HUVEC cells were transfected with either control siRNA or KDM2A siRNA (75 pmol). 24 hr later, cells were plated on matrigel in complete media (asynchronous) or with or without 100 ng/ml VEGF. …”
  17. 15137

    COVID19 effect on essential services. by Admas Abera (11821659)

    Published 2024
    “…On the other hand, the mean number of patients screened for diabetes and hypertension during the pandemic increased by more than 1014 (β: 1014.5; 95%CI: 103.07, 1925.92) and 610 patients (β: 611.21; 95%CI: 302.42, 919.99), respectively. …”
  18. 15138
  19. 15139

    Supplementary Material for: Oral L-Arginine (5 g/day) for 14 Days Improves Microcirculatory Function in Healthy Young Women and Healthy and Type 2 Diabetes Mellitus Elderly Women by Costa G. (3075237)

    Published 2021
    “…All patients underwent biochemical analysis (fasting glycemia and lipidogram), arterial blood pressure, nailfold videocapillaroscopy (capillary diameters, functional capillary density [FCD], peak red blood cell velocity [RBCV<sub>max</sub>] after 1 min ischemia, time to reach peak RBCV [TRBCV<sub>max</sub>]), and venous occlusion plethysmography (vasoreactivity), before and after 14 days of oral supplementation with L-arginine (5 g/day). <b><i>Results:</i></b> L-Arginine did not change fasting glycemia and lipidogram, but it decreased systolic, diastolic, and mean arterial pressure in elderly women, increased RBCV<sub>max</sub> in all groups, and did not decrease TRBCV<sub>max</sub> in T2DME. …”
  20. 15140